These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12596264)

  • 21. Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain.
    Davies P; Watt K; Kelly SM; Clark C; Price NC; McEwan IJ
    J Mol Endocrinol; 2008 Nov; 41(5):301-14. PubMed ID: 18762554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra- and intermolecular beta-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases.
    Tanaka M; Morishima I; Akagi T; Hashikawa T; Nukina N
    J Biol Chem; 2001 Nov; 276(48):45470-5. PubMed ID: 11584007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.
    Chai Y; Shao J; Miller VM; Williams A; Paulson HL
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9310-5. PubMed ID: 12084819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3.
    Gales L; Cortes L; Almeida C; Melo CV; Costa MC; Maciel P; Clarke DT; Damas AM; Macedo-Ribeiro S
    J Mol Biol; 2005 Oct; 353(3):642-54. PubMed ID: 16194547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular biology of polyglutamine diseases].
    Owecki M; Kozubski W
    Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms to control degradation of polyglutamine-containing protein].
    Nakayama K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):906-8. PubMed ID: 15152500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM; Bottomley SP
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodegeneration: RNA turns number one suspect in polyglutamine diseases.
    Birman S
    Curr Biol; 2008 Aug; 18(15):R659-R661. PubMed ID: 18682207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenic agent in Drosophila models of 'polyglutamine' diseases.
    McLeod CJ; O'Keefe LV; Richards RI
    Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats.
    Hussey J; Lockhart PJ; Seltzer W; Wszolek ZK; Payami H; Hanson M; Gwinn-Hardy K; Farrer M
    Genet Test; 2002; 6(3):217-20. PubMed ID: 12490063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A method for the incremental expansion of polyglutamine repeats in recombinant proteins.
    Robertson AL; Bottomley SP
    Methods Mol Biol; 2013; 1017():73-83. PubMed ID: 23719908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
    Preisinger E; Jordan BM; Kazantsev A; Housman D
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research progress in roles of microRNA in polyglutamine diseases].
    Shi YT; Jiang H; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):406-9. PubMed ID: 20677146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single amino acid and trinucleotide repeats: function and evolution.
    Faux N
    Adv Exp Med Biol; 2012; 769():26-40. PubMed ID: 23560303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural modeling of ataxin-3 reveals distant homology to adaptins.
    Albrecht M; Hoffmann D; Evert BO; Schmitt I; Wüllner U; Lengauer T
    Proteins; 2003 Feb; 50(2):355-70. PubMed ID: 12486728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the enlargement of polyglutamine segments on the structure and folding of ataxin-2 and ataxin-3 proteins.
    Wen J; Scoles DR; Facelli JC
    J Biomol Struct Dyn; 2017 Feb; 35(3):504-519. PubMed ID: 26861241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High pressure, an alternative approach to understand protein misfolding diseases.
    Torrent J; Marchal S; Tortora P; Lange R; Balny C
    Cell Mol Biol (Noisy-le-grand); 2004 Jun; 50(4):377-85. PubMed ID: 15529748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamine repeats and neurodegenerative diseases: molecular aspects.
    Perutz MF
    Trends Biochem Sci; 1999 Feb; 24(2):58-63. PubMed ID: 10098399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly-L-glutamine forms cation channels: relevance to the pathogenesis of the polyglutamine diseases.
    Monoi H; Futaki S; Kugimiya S; Minakata H; Yoshihara K
    Biophys J; 2000 Jun; 78(6):2892-9. PubMed ID: 10827970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of glutamine deamidation in neurodegenerative diseases associated with triplet repeat expansions: a hypothesis.
    Hasan Q; Alluri RV; Rao P; Ahuja YR
    J Mol Neurosci; 2006; 29(1):29-33. PubMed ID: 16757807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.